Rochelle Maher

Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial

Johan Maertens, Issam Raad, Kieren A. Marr et al. · The Lancet · 2015 · 972 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis

Francisco M. Marty, Luis Ostrosky‐Zeichner, Oliver A. Cornely et al. · The Lancet Infectious Diseases · 2016 · 694 citations

Medicine, Pharmacology, Pharmacotherapy +15

Phase III study comparing methotrexate and tacrolimus (prograf, FK506) with methotrexate and cyclosporine for graft-versus-host disease prophylaxis after HLA-identical sibling bone marrow transplantation.

Voravit Ratanatharathorn, Richard A. Nash, Donna Przepiorka et al. · PubMed · 1998 · 568 citations

Life Sciences, Immunology, Pharmacology +16

Isavuconazole Treatment of Cryptococcosis and Dimorphic Mycoses

George R. Thompson, Adrián Rendón, Rodrigo Ribeiro dos Santos et al. · Clinical Infectious Diseases · 2016 · 215 citations · Full text

Pharmacy, Microbiology, Pharmacotherapy +17

The impact of tacrolimus ointment on health-related quality of life of adult and pediatric patients with atopic dermatitis

Lynn A. Drake, Mary M. Prendergast, Rochelle Maher et al. · Journal of the American Academy of Dermatology · 2001 · 146 citations

Medicine, Dermatology, Immunology +16